Glycemic outcomes were significantly better across a range of groups.
Automated insulin delivery systems are insulin pumps that use continuous glucose monitoring (CGM) data to adjust insulin delivery automatically. These devices already are available for patients with type 1 diabetes, but their use in patients with type 2 diabetes has not been evaluated broadly.
In this industry-sponsored North American trial, researchers randomized 319 adults with type 2 diabetes who used insulin (multiple daily injections or traditional insulin pump) either to use an automated delivery system or to continue their usual method of insulin use; all patients received CGM. Patients who took other guideline-recommended medications were well represented. After 13 weeks, glycosylated hemoglobin (HbA1c) decreased significantly more i…
Reviewing Author
DisclosuresNothing to disclose
DisclosuresNothing to disclose